Stockpicker Comparison Tool
Nothing here is comparable yet for these companies.
Revenue Growth
CIA.AX
-8.32%
▼ -5.78%
EMR.AX
79.71%
▲ 35.19%
Gross Margin
CIA.AX
5.85%
▼ -25.94%
EMR.AX
68.98%
▲ 16.33%
Free Cash Flow
CIA.AX
-$36.12M
▼ -$80.47M
EMR.AX
$141.52M
▲ $64.47M
Net Debt / EBITDA
CIA.AX
2.50
▲ 0.99
EMR.AX
-0.67
▼ -0.10
Operating Margin
CIA.AX
-0.08%
▼ -13.90%
EMR.AX
68.15%
▲ 16.64%
P/E Ratio
CIA.AX
12.22
▼ -2.32
EMR.AX
13.09
▼ -4.79